AI can’t detect cancer. Dogs with BCIs can. Dognosis co-founder Akash Kulgod spent his Berkeley cognitive science thesis on canine olfaction, then built a company around it with an ex-IDF K9 handler. He explains how 15 beagles in Bangalore screen for seven cancers from a 10-minute breath sample, why the nose is the sensor but the dog’s brain is the actual readout, how a 1,502-person study in the Journal of Clinical Oncology hit 90.8% sensitivity and 91.3% specificity, what it costs to run the trial in India instead of California, and why the best multi-cancer screening device may already have four legs. Hosted by Mgoes → https://x.com/m_goes_distance Brought to you by SuperHuman Fund → https://superhuman.fund/ Disclaimer: SuperHuman Fund is an investor in Dognosis. — 0:00 - Cancer-Sniffing Dogs 8:10 - Largest Dog Clinical Study 12:50 - Training Dogs vs AI 17:30 - Sniffmaxxing Equation 22:20 - Dog BCI & AI Modeling 27:10 - Frontline Cancer Screening 33:40 - India vs US 38:10 - Dogs Post-AI-Merge 43:50 - Digitizing Smell 48:40 - Dog Telepathy 52:25 - Spreading Dogtimism — The Accelerate Bio Podcast explores the future of humanity in the age of Artificial Intelligence. Subscribe for deep-dive conversations with founders, scientists, and investors shaping AI, biotechnology, and human progress. — This episode discusses Akash Kulgod, Dognosis, BreathEasy, DogSense, DogOS, SniffSpace, Itamar Bitan, canine olfaction, cancer detection dogs, medical detection dogs, volatile organic compounds, VOC breath analysis, breath test, multi-cancer early detection, MCED, Grail, Galleri, liquid biopsy, brain-computer interface, animal BCI, neural decoding, beagles, machine learning diagnostics, cancer screening, early detection, oncology, Bangalore startups, India healthcare, clinical trials, Accel India, Boost VC, Draper Associates, The House Fund, UC Berkeley.
